HPS Corporate Capital Solutions Fund 8-K
Research Summary
AI-generated summary
HPS Corporate Capital Solutions Fund Reports Share Sales, NAV & Distributions
What Happened
- HPS Corporate Capital Solutions Fund filed an 8-K (Mar 27, 2026) announcing that it sold common shares on March 1, 2026 (purchase price and amounts finalized Mar 26, 2026 at $27.00 per share), reported net asset value as of Feb. 28, 2026, and declared both regular and special distributions on March 26, 2026.
- The Fund reported NAV per share of $27.00 for Class I, Class D and Class S as of Feb. 28, 2026, aggregate NAV of $1,299.2 million, investment portfolio fair value of $2,283.2 million, and principal debt outstanding of $994.2 million (average debt-to-equity ~0.76x in Feb. 2026).
Key Details
- March 1, 2026 share sales (price finalized Mar 26 at $27.00/share): Class I — 129,220 shares ($3.49M); Class D — 1,560,200 shares ($42.13M); Class S — none. Issuances were made under subscription agreements and exempt from registration under Section 4(a)(2) and Regulation D or S.
- Cumulative offering through the Mar 1, 2026 subscription date: 48,536,277 shares issued for total consideration of ~$1,264.72M (Class I 3,022,822 shares / $81.28M; Class D 45,513,455 shares / $1,183.43M).
- Distributions declared Mar 26, 2026: regular distribution of $0.1390 per share (net amounts: Class I $0.1390, Class D $0.1333, Class S $0.1195 after fees) payable to holders of record Mar 31, 2026 (payable on or about Apr 29, 2026); plus a special distribution of $0.16 per share payable to holders of record Mar 31, 2026 (payable on or about Apr 30, 2026). Cash or reinvestment under the Fund’s DRIP available.
Why It Matters
- For investors, the filing provides current liquidity and capital-raising activity (new share issuances at $27.00), the Fund’s stated NAV and balance-sheet magnitudes (assets, debt, and leverage), and near-term income from the declared regular and special distributions.
- The offering relied on investor accreditation or non‑U.S. status (Reg D/Reg S exemptions), and the Fund plans to continue monthly share sales, which can affect supply of shares and overall capital available for the portfolio.